Editorial commentary: Waning efficacy of the herpes zoster vaccine
- PMID: 25416752
- DOI: 10.1093/cid/ciu922
Editorial commentary: Waning efficacy of the herpes zoster vaccine
Keywords: efficacy; herpes zoster; vaccine.
Comment on
-
Long-term persistence of zoster vaccine efficacy.Clin Infect Dis. 2015 Mar 15;60(6):900-9. doi: 10.1093/cid/ciu918. Epub 2014 Nov 20. Clin Infect Dis. 2015. PMID: 25416754 Free PMC article.
Similar articles
-
Commentary regarding: Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. H Lal, AL Cunningham, O Godeaux et al., N Engl J Med 372:2087-2096, 2015.Dermatol Ther. 2016 Sep;29(5):300-301. doi: 10.1111/dth.12330. Epub 2016 Jan 22. Dermatol Ther. 2016. PMID: 26798973 No abstract available.
-
Recombinant Zoster Vaccine (Shingrix) to Prevent Herpes Zoster.Nurs Womens Health. 2018 Oct;22(5):417-422. doi: 10.1016/j.nwh.2018.07.004. Epub 2018 Aug 24. Nurs Womens Health. 2018. PMID: 30145235
-
Herpes Zoster Vaccination: Controversies and Common Clinical Questions.Gerontology. 2016;62(2):150-4. doi: 10.1159/000431374. Epub 2015 Jul 16. Gerontology. 2016. PMID: 26184711
-
Herpes zoster vaccine: clinical trial evidence and implications for medical practice.J Am Osteopath Assoc. 2007 Mar;107(3 Suppl 1):S14-8. J Am Osteopath Assoc. 2007. PMID: 17488883 Review.
-
Herpes zoster virus vaccine.Geriatrics. 2008 Oct;63(10):6-9. Geriatrics. 2008. PMID: 18828650 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
